Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

The impact of age on risk assessment, therapeutic practice and outcome in candidemia.

Hesstvedt L, Gaustad P, Müller F, Torp Andersen C, Brunborg C, Mylvaganam H, Leiva RA, Erik Berdal J, Egil Ranheim T, Johnsen BO, Falch BM, Grimnes G, Skogen V, Haarr E, Sandmo Lyngøy A, Wik Larssen K, Hannula R, Åsheim Hansen B, Nordøy I; Norwegian Fungal Network.

Infect Dis (Lond). 2019 Jun;51(6):425-434. doi: 10.1080/23744235.2019.1595709. Epub 2019 Apr 23.

PMID:
31010380
2.

Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study.

Barlinn R, Dudman SG, Trogstad L, Gibory M, Muller F, Magnus P, Rollag H.

APMIS. 2018 Dec;126(12):899-906. doi: 10.1111/apm.12899. Epub 2018 Oct 30.

PMID:
30378168
3.

Correction: Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting.

Knudsen PK, Brandtzaeg P, Høiby EA, Bohlin J, Samuelsen Ø, Steinbakk M, Abrahamsen TG, Müller F, Gammelsrud KW.

PLoS One. 2018 Feb 21;13(2):e0193439. doi: 10.1371/journal.pone.0193439. eCollection 2018.

4.

An Estimate of the Burden of Fungal Disease in Norway.

Nordøy I, Hesstvedt L, Torp Andersen C, Mylvaganam H, Kols NI, Falch BM, Tofteland S, Müller F, Denning DW.

J Fungi (Basel). 2018 Feb 21;4(1). pii: E29. doi: 10.3390/jof4010029.

5.

Transfer of a bla CTX-M-1-carrying plasmid between different Escherichia coli strains within the human gut explored by whole genome sequencing analyses.

Knudsen PK, Gammelsrud KW, Alfsnes K, Steinbakk M, Abrahamsen TG, Müller F, Bohlin J.

Sci Rep. 2018 Jan 10;8(1):280. doi: 10.1038/s41598-017-18659-2.

6.

Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting.

Knudsen PK, Brandtzaeg P, Høiby EA, Bohlin J, Samuelsen Ø, Steinbakk M, Abrahamsen TG, Müller F, Gammelsrud KW.

PLoS One. 2017 Nov 7;12(11):e0187618. doi: 10.1371/journal.pone.0187618. eCollection 2017. Erratum in: PLoS One. 2018 Feb 21;13(2):e0193439.

7.

No associations established between single nucleotide polymorphisms in human Toll-like receptor 2 and Toll-interacting protein and Staphylococcus aureus bloodstream infections.

Smeland TE, Müller F, Blomfeldt A, Stavem K, Aamot HV.

APMIS. 2017 Oct;125(10):927-932. doi: 10.1111/apm.12734. Epub 2017 Jul 24.

PMID:
28736863
8.

Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery.

Stav-Noraas TE, Edelmann RJ, Poulsen LC, Sundnes O, Phung D, Küchler AM, Müller F, Kamen AA, Haraldsen G, Kaarbø M, Hol J.

J Immunol. 2017 Apr 15;198(8):3318-3325. doi: 10.4049/jimmunol.1600054. Epub 2017 Mar 3.

9.

Correction for Blomfeldt et al., Molecular Characterization of Methicillin-Sensitive Staphylococcus aureus Isolates from Bacteremic Patients in a Norwegian University Hospital.

Blomfeldt A, Aamot HV, Eskesen AN, Müller F, Monecke S.

J Clin Microbiol. 2016 Sep;54(9):2404. doi: 10.1128/JCM.01436-16. Epub 2016 Aug 24. No abstract available.

10.

Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome.

Siljan WW, Holter JC, Nymo SH, Schjalm C, Müller F, Jenum PA, Husebye E, Ueland T, Aukrust P, Mollnes TE, Heggelund L.

J Infect. 2016 Oct;73(4):383-6. doi: 10.1016/j.jinf.2016.07.011. Epub 2016 Jul 21. No abstract available.

PMID:
27452197
11.

A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology.

Fryer JF, Heath AB, Minor PD; Collaborative Study Group.

Biologicals. 2016 Jul;44(4):242-251. doi: 10.1016/j.biologicals.2016.04.005. Epub 2016 May 11.

12.

Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study.

Holter JC, Ueland T, Jenum PA, Müller F, Brunborg C, Frøland SS, Aukrust P, Husebye E, Heggelund L.

PLoS One. 2016 Feb 5;11(2):e0148741. doi: 10.1371/journal.pone.0148741. eCollection 2016.

13.

Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy.

Broch K, Andreassen AK, Hopp E, Leren TP, Scott H, Müller F, Aakhus S, Gullestad L.

Open Heart. 2015 Oct 9;2(1):e000271. doi: 10.1136/openhrt-2015-000271. eCollection 2015.

14.

Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway.

Holter JC, Müller F, Bjørang O, Samdal HH, Marthinsen JB, Jenum PA, Ueland T, Frøland SS, Aukrust P, Husebye E, Heggelund L.

BMC Infect Dis. 2015 Feb 15;15:64. doi: 10.1186/s12879-015-0803-5.

15.

[Re: Hearing loss in children in Östfold county 2000-09].

Rollag H, Holter E, Müller F.

Tidsskr Nor Laegeforen. 2015 Mar 24;135(6):513. doi: 10.4045/tidsskr.15.0262. eCollection 2015 Mar 24. Norwegian. No abstract available.

16.

A worrying trend in weight-adjusted paediatric antibiotic use in a Norwegian tertiary care hospital.

Raastad R, Tvete IF, Abrahamsen TG, Berild D, Leegaard TM, Walberg M, Müller F.

Acta Paediatr. 2015 Jul;104(7):687-92. doi: 10.1111/apa.12994. Epub 2015 Apr 1.

PMID:
25753620
17.

Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial.

Sulheim D, Fagermoen E, Winger A, Andersen AM, Godang K, Müller F, Rowe PC, Saul JP, Skovlund E, Øie MG, Wyller VB.

JAMA Pediatr. 2014 Apr;168(4):351-60. doi: 10.1001/jamapediatrics.2013.4647.

PMID:
24493300
18.

Molecular characterization of methicillin-sensitive Staphylococcus aureus isolates from bacteremic patients in a Norwegian University Hospital.

Blomfeldt A, Aamot HV, Eskesen AN, Müller F, Monecke S.

J Clin Microbiol. 2013 Jan;51(1):345-7. doi: 10.1128/JCM.02571-12. Epub 2012 Nov 7. Erratum in: J Clin Microbiol. 2016 Sep;54(9):2404.

19.

Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment.

Aldrin M, Raastad R, Tvete IF, Berild D, Frigessi A, Leegaard T, Monnet DL, Walberg M, Müller F.

Stat Med. 2013 Apr 15;32(8):1407-18. doi: 10.1002/sim.5636. Epub 2012 Oct 1.

PMID:
23027651
20.

The role of properdin in zymosan- and Escherichia coli-induced complement activation.

Harboe M, Garred P, Lindstad JK, Pharo A, Müller F, Stahl GL, Lambris JD, Mollnes TE.

J Immunol. 2012 Sep 1;189(5):2606-13. doi: 10.4049/jimmunol.1200269. Epub 2012 Jul 30.

Supplemental Content

Loading ...
Support Center